Table 3. Paired tissues from AA, CA and SKR TNBC patients samples.
| Sample | ID | Receptor status | Age | Ethnic group |
|---|---|---|---|---|
| Normal | 1M | ER-/PR-/Her2- | 59 | AA |
| Tumor | 2N | |||
| Normal | 3M | ER-/PR-/Her2- | 46 | AA |
| Tumor | 4N | |||
| Normal | 5M | ER-/PR-/Her2- | 36 | AA |
| Tumor | 6N | |||
| Normal | 7M | ER-/PR-/Her2- | 42 | AA |
| Tumor | 8N | |||
| Normal | 9M | ER-/PR-/Her2- | 60 | AA |
| Tumor | 10N | |||
| Normal | 1M | ER-/PR-/Her2- | 43 | CA |
| Tumor | 2N | |||
| Normal | 3M | ER-/PR-/Her2- | 91 | CA |
| Tumor | 4N | |||
| Normal | 5M | ER-/PR-/Her2- | 63 | CA |
| Tumor | 6N | |||
| Normal | 7M | ER-/PR-/Her2- | 72 | CA |
| Tumor | 8N | |||
| Normal | 9M | ER-/PR-/Her2- | 63 | CA |
| Tumor | 10N | |||
| Normal | 1M | ER-/PR-/Her2- | 44 | SKR |
| Tumor | 2N | |||
| Normal | 3M | ER-/PR-/Her2- | 44 | SKR |
| Tumor | 4N | |||
| Normal | 5M | ER-/PR-/Her2- | 63 | SKR |
| Tumor | 6N | |||
| Normal | 7M | ER-/PR-/Her2- | 41 | SKR |
| Tumor | 8N |